Class ITerminatedD-0100-2024
Drug recall · November 15, 2023
4.2% Sodium Bicarbonate Injection recall
Why: Presence of Particulate Matter: identified as glass.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5mEq/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector per carton, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-5534-24
- Lots / codes
Lot#: GJ5007, Exp. 8/1/2024
- Quantity
- 24,900 vials
- Company
- Pfizer Inc., New York, NY
- Distribution
- Nationwide in the US and Puerto Rico. The products were not distributed to government accounts or foreign consignees.
- Initiated
- October 2, 2023 · Voluntary: Firm initiated
- Classified
- November 9, 2023
- Reported
- November 15, 2023
- Ended
- February 14, 2025
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.